Publisher： John Wiley & Sons Inc
ISSN： 0044-8249
Source： ANGEWANDTE CHEMIE, Vol.127, Iss.13, 2015-03, pp. : 4090-4094
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
We present a silica nanoparticle (SNP) functionalized with polyphosphate (polyP) that accelerates the natural clotting process of the body. SNPs initiate the contact pathway of the blood‐clotting system; short‐chain polyP accelerates the common pathway by the rapid formation of thrombin, which enhances the overall blood‐clotting system, both by accelerating fibrin generation and by facilitating the regulatory anticoagulation mechanisms essential for hemostasis. Analysis of the clotting properties of bare SNPs, bare polyP, and polyP‐functionalized SNPs in plasma demonstrated that the attachment of polyP to SNPs to form polyP‐SNPs creates a substantially enhanced synergistic effect that lowers clotting time and increases thrombin production at low concentrations. PolyP‐SNP even retains its clotting function at ambient temperature. The polyP‐SNP system has the potential to significantly improve trauma‐treatment protocols and outcomes in hospital and prehospital settings.
Related content
Clotting Activity of Polyphosphate‐Functionalized Silica Nanoparticles
ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 54, Iss. 13, 2015-03 ,pp. :
Access to resources
Recommend
Mesoporous‐Silica‐Functionalized Nanoparticles for Drug Delivery
CHEMISTRY - A EUROPEAN JOURNAL, Vol. 21, Iss. 40, 2015-09 ,pp. :
By Orlyk S. Das P. Alekseenko L. Kapran A.
Theoretical and Experimental Chemistry, Vol. 49, Iss. 4, 2013-09 ,pp. :